ALX Oncology is a clinical-stage biotech company developing new cancer therapies aimed at improving patient outcomes. Its lead candidate, evorpacept, is being tested in multiple cancer types.

First Industrial Realty Trust advances U.S. logistics growth through development, operations, and tenant-focused industrial ...

Hyster-Yale supports global lift truck operations through engineering strength, manufacturing scale, and extensive dealer ...

Ultrapar Participações expands energy distribution, retail services, and infrastructure programs across Brazil’s essential ...

Parsons Corporation strengthens defense, cybersecurity, and infrastructure capabilities through integrated global solutions.

National Presto Industries advances household, safety, and defense operations as trading interest increases across its ...

Dingdong Cayman strengthens its fresh grocery platform through integrated supply chains and expanded digital distribution.

Devon Energy (NYSE:DVN) supports U.S. exploration and production as s&p 500 today highlights broad sector activity.

Remitly Global (NASDAQ:RELY) drives cross-border remittance and financial inclusion, aligning with trends in nasdaq futures.

PepsiCo (NASDAQ:PEP) maintains global relevance as nasdaq composite etf discussions highlight companies with broad ...

Honeywell (NASDAQ:HON) drives market growth through innovation in aerospace, automation, and sustainability, contributing to ...

Trip.com Group (NASDAQ:TCOM) drives travel industry innovation, contributing to trends in the nasdaq composite with its ...